September Could be Kind to Biotechnology ETFs

The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotechnology exchange traded fund by assets, is up nearly 18% and the behemoth biotech fund could add to those gains in September. The ninth month of the year sets up favorably for some of IBB’s marquee holdings. Biotech ETFs...